Vivo Ventures VII Affiliates
QuietPalo Alto, CAHealthcare, Biotechnology, PharmaceuticalsLast fund filed December 2011
3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Vivo Ventures VII Affiliates Fund | December 2011 | $6.4M | $6.4M | 31 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Albert Cha | Quiet | Biotech & pharma, Medical devices | 8 | 0 |
| Edgar Engleman | Quiet | Biotech & pharma, Medical devices | 4 | 0 |
| Frank Kung | Quiet | Biotech & pharma | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Vivo Ventures VII Affiliates’s own portfolio companies, based on 13 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vivo Ventures VII Affiliates’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Vivo Innovation | 12 | Aclaris Therapeutics, AIRXPANDERS, AMYRIS, Ascendis Pharma A/S, Bolt Biotherapeutics, Carbylan Therapeutics, EIGER BIOPHARMACEUTICALS, Eiger BioPharmaceuticals, Menlo Therapeutics, MINERVA SURGICAL, ProNAi Therapeutics, TRIA Beauty |
| Sofinnova Venture Partners | 3 | Aclaris Therapeutics, Ascendis Pharma A/S, Bolt Biotherapeutics |
| Aisling Capital | 2 | Aclaris Therapeutics, TRIA Beauty |
| Capra CLO Founders | 2 | Ascendis Pharma A/S, Bolt Biotherapeutics |
| Forest City Enterprises | 2 | Aclaris Therapeutics, Menlo Therapeutics |
| Gran Paradiso Capital Partners | 2 | Ascendis Pharma A/S, Bolt Biotherapeutics |
| Orbimed Asia Partners | 2 | Ascendis Pharma A/S, ProNAi Therapeutics |
| Orbimed Genesis | 2 | Ascendis Pharma A/S, ProNAi Therapeutics |
| Caduceus Capital | 1 | Ascendis Pharma A/S |
| Khosla Ventures | 1 | AMYRIS |
| Nexeption Capital | 1 | Aclaris Therapeutics |
| Pivotal bioVenture Partners | 1 | Bolt Biotherapeutics |
| Venbio Global Strategic | 1 | Menlo Therapeutics |
| Versant Affiliates | 1 | MINERVA SURGICAL |
| Versant Venture Capital | 1 | MINERVA SURGICAL |
A shared board seat: a company where filings name a Vivo Ventures VII Affiliates partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.